Intravitreal Aflibercept in Wet Age Related Macular Degeneration Patients With an Incomplete Response to Routine Ranibizumab Injections
Clinical trial NCT02002377 · TERMINATED
Trial details
- NCT number
- NCT02002377
- Sponsor
- Unity Health Toronto
- Status
- TERMINATED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2014-04-17
- Primary completion
- 2017-02-21
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.